celecoxib has been researched along with acetyl-11-ketoboswellic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jauch, J; Noha, SM; Paul, M; Schuster, D; Seitz, S; Verhoff, M; Werz, O | 1 |
| El Sayed, NS; Sayed, AS | 1 |
2 other study(ies) available for celecoxib and acetyl-11-ketoboswellic acid
| Article | Year |
|---|---|
Tetra- and pentacyclic triterpene acids from the ancient anti-inflammatory remedy frankincense as inhibitors of microsomal prostaglandin E(2) synthase-1.
Topics: Animals; Anti-Inflammatory Agents; Boswellia; Characidae; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Inhibitory Concentration 50; Intramolecular Oxidoreductases; Lipoxygenase Inhibitors; Molecular Structure; Pentacyclic Triterpenes; Prostaglandin Antagonists; Prostaglandin-E Synthases; Resins, Plant; Structure-Activity Relationship; Tetracycline; Triterpenes | 2014 |
Co-administration of 3-Acetyl-11-Keto-Beta-Boswellic Acid Potentiates the Protective Effect of Celecoxib in Lipopolysaccharide-Induced Cognitive Impairment in Mice: Possible Implication of Anti-inflammatory and Antiglutamatergic Pathways.
Topics: Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Celecoxib; Cognitive Dysfunction; Cyclooxygenase 2 Inhibitors; Drug Combinations; Drug Synergism; Glutamic Acid; Lipopolysaccharides; Lipoxygenase Inhibitors; Male; Mice; Triterpenes; Tumor Necrosis Factor-alpha | 2016 |